Endpoints included measurements of inflammatory markers ( C-reactive protein and interleukin 6 ) , oxidative status ( total antioxidant power and malondialdehyde ) , lipid profiles ( plasma total cholesterol , triacylglycerols , and high-density lipoprotein cholesterol ) , as well as cholesteryl-ester transfer protein activity and apolipoprotein A1 .